Published in Br J Pharmacol on October 03, 2006
New tricks for old dogs: KCNQ expression and role in smooth muscle. Br J Pharmacol (2009) 1.32
Loss of functional K+ channels encoded by ether-à-go-go-related genes in mouse myometrium prior to labour onset. J Physiol (2009) 1.01
Voltage clamp studies of a transient outward membrane current in gastropod neural somata. J Physiol (1971) 9.27
Modulation of A-type potassium channels by a family of calcium sensors. Nature (2000) 5.62
Molecular diversity of K+ channels. Ann N Y Acad Sci (1999) 4.63
International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels. Pharmacol Rev (2005) 3.50
Structure and function of Kv4-family transient potassium channels. Physiol Rev (2004) 2.47
Electrophysiological and functional effects of the KCNQ channel blocker XE991 on murine portal vein smooth muscle cells. Br J Pharmacol (2005) 1.54
Molecular variants of KCNQ channels expressed in murine portal vein myocytes: a role in delayed rectifier current. Circ Res (2003) 1.53
A voltage-dependent outward current with fast kinetics in single smooth muscle cells isolated from rabbit portal vein. J Physiol (1989) 1.50
Electrophysiological and pharmacological correspondence between Kv4.2 current and rat cardiac transient outward current. Cardiovasc Res (1997) 1.42
Molecular cloning and tissue distribution of an alternatively spliced variant of an A-type K+ channel alpha-subunit, Kv4.3 in the rat. FEBS Lett (1997) 1.35
Characteristics of transient outward currents in single smooth muscle cells from the ureter of the guinea-pig. J Physiol (1990) 1.25
Electrophysiological and molecular identification of voltage-gated sodium channels in murine vascular myocytes. J Physiol (2005) 1.24
A-type potassium currents in smooth muscle. Am J Physiol Cell Physiol (2003) 1.21
Effects of phrixotoxins on the Kv4 family of potassium channels and implications for the role of Ito1 in cardiac electrogenesis. Br J Pharmacol (1999) 1.16
Angiotensin receptor type 1 forms a complex with the transient outward potassium channel Kv4.3 and regulates its gating properties and intracellular localization. J Biol Chem (2004) 1.15
Comparison of the properties of CLCA1 generated currents and I(Cl(Ca)) in murine portal vein smooth muscle cells. J Physiol (2002) 1.14
Functional and molecular identification of ERG channels in murine portal vein myocytes. Am J Physiol Cell Physiol (2002) 1.12
Regulation of Kv4.3 currents by Ca2+/calmodulin-dependent protein kinase II. Am J Physiol Cell Physiol (2004) 1.11
Diversity of voltage-dependent K+ channels in human pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol (2004) 1.01
Novel regulation of the A-type K+ current in murine proximal colon by calcium-calmodulin-dependent protein kinase II. J Physiol (1999) 1.00
Voltage-gated K+ currents in freshly isolated myocytes of the pregnant human myometrium. J Physiol (1999) 0.98
Contribution of Kv channels to phenotypic remodeling of human uterine artery smooth muscle cells. Circ Res (2005) 0.98
Characterization of the A-type potassium current in murine gastric antrum. J Physiol (2002) 0.92
Role of HERG-like K(+) currents in opossum esophageal circular smooth muscle. Am J Physiol (1999) 0.87
Contribution of Kv4 channels toward the A-type potassium current in murine colonic myocytes. J Physiol (2002) 0.86
Differential transcriptional expression of Ca2+ BP superfamilies in murine gastrointestinal smooth muscles. Am J Physiol Gastrointest Liver Physiol (2002) 0.82
Molecular and pharmacological characteristics of transient voltage-dependent K+ currents in cultured human pulmonary arterial smooth muscle cells. Br J Pharmacol (2005) 0.79
Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1992) 4.74
Outer membrane proteins responsible for multiple drug resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1995) 3.98
Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM efflux pumps in Pseudomonas aeruginosa. Antimicrob Agents Chemother (2000) 3.78
Contribution of the MexX-MexY-oprM efflux system to intrinsic resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother (2000) 2.67
Quantitative correlation between susceptibility and OprJ production in NfxB mutants of Pseudomonas aeruginosa. Antimicrob Agents Chemother (1996) 2.18
K+ currents regulate the resting membrane potential, proliferation, and contractile responses in ventricular fibroblasts and myofibroblasts. Am J Physiol Heart Circ Physiol (2005) 1.89
Molecular expression and pharmacological identification of a role for K(v)7 channels in murine vascular reactivity. Br J Pharmacol (2007) 1.75
Increase in susceptibility of Pseudomonas aeruginosa to carbapenem antibiotics in low-amino-acid media. Antimicrob Agents Chemother (1991) 1.61
TREK-1 regulation by nitric oxide and cGMP-dependent protein kinase. An essential role in smooth muscle inhibitory neurotransmission. J Biol Chem (2001) 1.47
Interplay between chromosomal beta-lactamase and the MexAB-OprM efflux system in intrinsic resistance to beta-lactams in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1999) 1.46
Incidence of various gyrA mutants in 451 Staphylococcus aureus strains isolated in Japan and their susceptibilities to 10 fluoroquinolones. Antimicrob Agents Chemother (1995) 1.44
Hydrophilicity of quinolones is not an exclusive factor for decreased activity in efflux-mediated resistant mutants of Staphylococcus aureus. Antimicrob Agents Chemother (1996) 1.42
New cephamycin antibiotic, CS-1170: binding affinity to penicillin-binding proteins and inhibition of peptidoglycan cross-linking reactions in Escherichia coli. Antimicrob Agents Chemother (1978) 1.37
Dual effect of blocking agents on Ca2+-activated Cl(-) currents in rabbit pulmonary artery smooth muscle cells. J Physiol (2002) 1.36
Local Ca(2+) transients and distribution of BK channels and ryanodine receptors in smooth muscle cells of guinea-pig vas deferens and urinary bladder. J Physiol (2001) 1.35
Interstitial cells in the vasculature. J Cell Mol Med (2005) 1.28
Calcium oscillations in interstitial cells of the rabbit urethra. J Physiol (2005) 1.28
Penicillin-binding proteins in Proteus species. J Bacteriol (1979) 1.26
Organization and function of ICC in the urinary tract. J Physiol (2006) 1.22
Antibacterial activity of cefmetazole alone and in combination with fosfomycin against methicillin- and cephem-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1986) 1.18
Effect of niflumic acid on noradrenaline-induced contractions of the rat aorta. Br J Pharmacol (1996) 1.18
Isolation and structure of dynorphin, an opioid peptide, from porcine duodenum. Nature (1982) 1.16
Activity of the carbapenem panipenem and role of the OprD (D2) protein in its diffusion through the Pseudomonas aeruginosa outer membrane. Antimicrob Agents Chemother (1993) 1.13
Direct visualization of sarcoplasmic reticulum regions discharging Ca(2+)sparks in vascular myocytes. Cell Calcium (2001) 1.10
Bimodal effects of the Kv7 channel activator retigabine on vascular K+ currents. Br J Pharmacol (2008) 1.06
C-type natriuretic peptide activates a non-selective cation current in acutely isolated rat cardiac fibroblasts via natriuretic peptide C receptor-mediated signalling. J Physiol (2007) 1.03
Loss of functional K+ channels encoded by ether-à-go-go-related genes in mouse myometrium prior to labour onset. J Physiol (2009) 1.01
Activation of potassium currents by inhibitors of calcium-activated chloride conductance in rabbit portal vein smooth muscle cells. Br J Pharmacol (1996) 1.00
Modulation of volume-sensitive chloride current by noradrenaline in rabbit portal vein myocytes. J Physiol (2002) 0.97
Nature of magnetic coupling between Mn ions in As-grown Ga1-xMnxAs studied by X-ray magnetic circular dichroism. Phys Rev Lett (2008) 0.97
In vitro and in vivo antibacterial activities of CS-834, a novel oral carbapenem. Antimicrob Agents Chemother (1997) 0.96
Modulation of spontaneous Ca2+-activated Cl- currents in the rabbit corpus cavernosum by the nitric oxide-cGMP pathway. J Physiol (2004) 0.94
Hypersusceptibility of the Pseudomonas aeruginosa nfxB mutant to beta-lactams due to reduced expression of the ampC beta-lactamase. Antimicrob Agents Chemother (2001) 0.92
One man's side effect is another man's therapeutic opportunity: targeting Kv7 channels in smooth muscle disorders. Br J Pharmacol (2013) 0.92
Inhibitory action of niflumic acid on noradrenaline- and 5-hydroxytryptamine-induced pressor responses in the isolated mesenteric vascular bed of the rat. Br J Pharmacol (1997) 0.91
Ca2+ spark as a regulator of ion channel activity. Jpn J Pharmacol (1999) 0.91
Purification and some properties of beta-lactamases from Proteus rettgeri and Proteus inconstans. Microbiol Immunol (1980) 0.91
Apamin-sensitive Ca2+-dependent K+ current and hyperpolarization in human endothelial cells. Biochem Biophys Res Commun (1997) 0.90
Dual modulation of swelling-activated chloride current by NO and NO donors in rabbit portal vein myocytes. J Physiol (2000) 0.90
Usefulness and limitation of DiBAC4(3), a voltage-sensitive fluorescent dye, for the measurement of membrane potentials regulated by recombinant large conductance Ca2+-activated K+ channels in HEK293 cells. Jpn J Pharmacol (2001) 0.90
Administration of killed bacteria together with listeriolysin O induces protective immunity against Listeria monocytogenes in mice. Immunology (1998) 0.90
Persistent production of interferon-gamma (IFN-gamma) and IL-12 is essential for the generation of protective immunity against Listeria monocytogenes. Clin Exp Immunol (1997) 0.90
Phosphorylation alters the pharmacology of Ca(2+)-activated Cl channels in rabbit pulmonary arterial smooth muscle cells. Br J Pharmacol (2009) 0.90
Cytokine-stimulated release of decay-accelerating factor (DAF;CD55) from HT-29 human intestinal epithelial cells. Clin Exp Immunol (1998) 0.89
Vasorelaxant effects of novel Kv 7.4 channel enhancers ML213 and NS15370. Br J Pharmacol (2014) 0.89
Inhibition of vascular calcium-gated chloride currents by blockers of KCa1.1, but not by modulators of KCa2.1 or KCa2.3 channels. Br J Pharmacol (2009) 0.89
Release of lipoteichoic acid from Staphylococcus aureus by treatment with cefmetazole and other beta-lactam antibiotics. J Antibiot (Tokyo) (1983) 0.89
Involvement of various combinations of endogenous inflammatory cytokines in Listeria monocytogenes-induced expression of inducible nitric oxide synthase in mice. FEMS Immunol Med Microbiol (1996) 0.87
Reactive oxygen species induced smooth muscle responses in the intestine, vessels and airways and the effect of antioxidants. Life Sci (1999) 0.86
Role of beta-lactamase of methicillin-susceptible Staphylococcus aureus in resistance to first-generation oral cephems both in vitro and in vivo. J Antimicrob Chemother (1994) 0.86
Cajal beyond the gut: interstitial cells in the urinary system--towards general regulatory mechanisms of smooth muscle contractility? Acta Gastroenterol Belg (2011) 0.86
Contribution of Kv2.1 channels to the delayed rectifier current in freshly dispersed smooth muscle cells from rabbit urethra. Am J Physiol Cell Physiol (2011) 0.84
Sub-plasmalemmal [Ca2+]i upstroke in myocytes of the guinea-pig small intestine evoked by muscarinic stimulation: IP3R-mediated Ca2+ release induced by voltage-gated Ca2+ entry. Cell Calcium (2007) 0.84
Efficacy of CS-834 against experimental pneumonia caused by penicillin-susceptible and -resistant Streptococcus pneumoniae in mice. Antimicrob Agents Chemother (1998) 0.84
Penem derivatives: beta-lactamase stability and affinity for penicillin-binding proteins in Escherichia coli. Antimicrob Agents Chemother (1982) 0.84
Activation of Ca2+-activated Cl- current by depolarizing steps in rabbit urethral interstitial cells. Am J Physiol Cell Physiol (2003) 0.83
Effect of 7 alpha substitution of cephems on their beta-lactamase stability and affinity for penicillin-binding proteins in Morganella morganii. Antimicrob Agents Chemother (1983) 0.83
Tonic regulation of vascular tone by nitric oxide and chloride ions in rat isolated small coronary arteries. Am J Physiol Heart Circ Physiol (2000) 0.83
Levcromakalim-induced modulation of membrane potassium currents, intracellular calcium and mechanical activity in rat mesenteric artery. Naunyn Schmiedebergs Arch Pharmacol (1994) 0.81
Inhibitory role of phosphatidylinositol 4,5-bisphosphate on TMEM16A-encoded calcium-activated chloride channels in rat pulmonary artery. Br J Pharmacol (2014) 0.81
Calcium release events in excitation-contraction coupling in smooth muscle. Novartis Found Symp (2002) 0.80
Effects of the novel BK (KCa 1.1) channel opener GoSlo-SR-5-130 are dependent on the presence of BKβ subunits. Br J Pharmacol (2015) 0.80
Ca2+ sensitization of smooth muscle contractility induced by ruthenium red. Am J Physiol (1999) 0.79
Decay-accelerating factor (DAF) in stool specimens as a marker of disease activity in patients with ulcerative colitis (UC). Clin Exp Immunol (1998) 0.79
Ionic currents in intimal cultured synoviocytes from the rabbit. Am J Physiol Cell Physiol (2010) 0.79
The PI-PLC inhibitor U-73122 is a potent inhibitor of the SERCA pump in smooth muscle. Br J Pharmacol (2010) 0.79
Purification and properties of beta-lactamase from Proteus vulgaris. Microbiol Immunol (1982) 0.78
[Remission induction after pentoxifylline treatment in a patient with rheumatoid arthritis]. Ryumachi (1997) 0.78
beta-Lactamase produced by a highly beta-lactam-resistant strain of Bacteroides fragilis: an obstacle to the chemotherapy of experimental mixed infections. J Antimicrob Chemother (1991) 0.78
Investigation of L-type Ca(2+) current in the aganglionic bowel segment in Hirschsprung's disease. Neurogastroenterol Motil (2012) 0.77
Inhibitory activity to protein prenylation and antifungal activity of zaragozic acid D3, a potent inhibitor of squalene synthase produced by the fungus, Mollisia sp. SANK 10294. J Antibiot (Tokyo) (1998) 0.77
The cardiac sodium current Na(v)1.5 is functionally expressed in rabbit bronchial smooth muscle cells. Am J Physiol Cell Physiol (2013) 0.77
[Inhibition of biofilm formation by clarithromycin (CAM) in an experimental model of complicated bladder infection--in vitro study using automated simulation of urinary antimicrobial concentration]. Kansenshogaku Zasshi (1994) 0.76
Synthesis and antibacterial activity of novel 1beta-methyl carbapenems with cycloalkylamine moiety at the C-2 position. J Antibiot (Tokyo) (2001) 0.76
Hypothalamic ATF3 is involved in regulating glucose and energy metabolism in mice. Diabetologia (2013) 0.76
Potent cephalosporinase inhibitors: 7 beta-[2-(1, 3-dithiolan-2-ylidene) acetamido] cephalosporins and related compounds. Antimicrob Agents Chemother (1982) 0.75
Complex role of Kv7 channels in cGMP and cAMP-mediated relaxations. Channels (Austin) (2015) 0.75
Synthesis and biological evaluation of new oral carbapenems with 1-methyl-5-oxopyrrolidin-3-ylthio moiety. J Antibiot (Tokyo) (1999) 0.75
Synthesis and in vitro antifungal activities of novel triazole antifungal agent CS-758. Chem Pharm Bull (Tokyo) (2001) 0.75
[Therapeutic study on biofilm of the urinary tract using a severely complicated bladder model (biofilm model of the urinary tract)--experimental study using an automatic simulator of urinary antimicrobial agent concentration, and clinical study]. Kansenshogaku Zasshi (1994) 0.75
Effects of AF64A on the mRNA levels of muscarinic receptor subtypes in the rat iris sphincter. J Smooth Muscle Res (2000) 0.75
Molecular cloning of m3 muscarinic acetylcholine receptor in rat iris. J Smooth Muscle Res (1998) 0.75
[Significance of the combined treatment with isepamicin and piperacillin in an in vitro model for complicated cystitis operated by automatic simulator apparatus for urinary concentration]. Kansenshogaku Zasshi (1992) 0.75
[Application of serum type III procollagen peptide level in the diagnosis of lung fibrosis developed during bleomycin treatment in cancer patients]. Nihon Gan Chiryo Gakkai Shi (1985) 0.75
[A clinical study on postantibiotic effect (PAE) and its application to chemotherapy for complicated cystitis with an automatic simulator of urinary drug concentration]. Kansenshogaku Zasshi (1992) 0.75
[Adaptation study for biofilm of the urinary tract via highly complicated bladder model (biofilm model of the urinary tract)--experimental study using automatic simulator of the urinary antimicrobial agent concentration]. Kansenshogaku Zasshi (1994) 0.75
Involvement of different Ca2+ sources in changes of responsiveness of guinea-pig trachea to repeated administration of histamine and acetylcholine. Gen Physiol Biophys (1995) 0.75
[In vitro and in vivo activities of panipenem against penicillin-resistant Streptococcus pneumoniae]. Jpn J Antibiot (2001) 0.75
[Smooth muscle preparations as models for studies of drug effects on organs]. Cesk Fysiol (1995) 0.75
[Combination effect of teicoplanin and panipenem on highly resistant strains of MRSA]. Jpn J Antibiot (1999) 0.75
[An in vitro study on the treatment of complicated cystitis using an automatic simulator]. Kansenshogaku Zasshi (1990) 0.75
Synthesis and biological evaluation of novel tricyclic carbapenems (trinems). J Antibiot (Tokyo) (2000) 0.75
[In vitro and in vivo activities of cefpodoxime proxetil against penicillin-resistant Streptococcus pneumoniae]. Jpn J Antibiot (1999) 0.75
Synthesis and antifungal activities of R-102557 and related dioxane-triazole derivatives. Chem Pharm Bull (Tokyo) (2000) 0.75
Molecular analysis of non-specific supersensitivity induced by AF64A in rat iris smooth muscle. J Smooth Muscle Res (2000) 0.75
[Combination effect between panipenem and vancomycin on highly methicillin-resistant Staphylococcus aureus]. Jpn J Antibiot (1997) 0.75